News

Eli Lilly's May Meltdown Is In History Books — Could June Seasonality Bring A Rebound?
Eli Lilly stock down 19% in May, on track for worst month since 2009. But June historically brings better fortune, with 67% ...
The American Bazaar4d
Eli Lilly to buy SiteOne for $1 billion
Pharmaceutical company Eli Lilly has announced plans to acquire private biotech company SiteOne in a deal worth up to $1 ...
BioPharma Dive5d
Lilly to buy pain drug developer SiteOne, challenging Vertex
The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.
Contract Pharma5d
Lilly Agrees to Acquire SiteOne Therapeutics
Eli Lilly and Company has agreed to acquire SiteOne Therapeutics Inc., a private biotech company developing small molecule ...
Dealbreaker on MSN4d
Eli Lilly Pays $1 Billion For Non-Opioid Pain Med Maker
Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
InvestorsHub on MSN5d
Eli Lilly Expands Pain Treatment Pipeline with SiteOne Therapeutics Acquisition
Eli Lilly and Company (NYSE:LLY) is advancing its neuroscience portfolio by acquiring SiteOne Therapeutics in a deal valued ...
Nasdaq6d
Eli Lilly and Company Common Stock (LLY) Dividend History
Stay up-to-date on Eli Lilly and Company Common Stock (LLY) Dividends, Current Yield, ... The Dividend History page provides a single page to review all of the aggregated Dividend payment information.
Investment Case For Eli Lilly Still Weak, Despite Novo Nordisk's Struggle
Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...
Lilly King announces 2025 will be her last season in competitive swimming
Lilly King, a 2016 Olympic champion and world record holder in the 100m breaststroke, announced that 2025 will be her final ...